To inspire and empower millions of people living with Parkinson’s around the world, Bial launches a touching campaign for the World Parkinson’s Day showing that it is possible to live a normal life, and successfully perform everyday tasks
Imagine being unable to control your own body. In your mind, everything is exactly like it was; but your brain seems to have forgotten how to tell your body to do everyday tasks like tying up shoes or using a toothbrush.
This is how it feels to live with Parkinson’s. A real challenge for the 10 million people diagnosed with Parkinson’s around the world. Parkinson’s is a progressive neurodegenerative disease – an illness that affects nerve cells in the brain. For those who live with these symptoms and for their families, Parkinson’s means much more than just physical symptoms: it also means a loss of their independence.
In order to raise awareness and help people keep their self-esteem, people with Parkinson’s were invited to star in a video that shows them at their best by focusing on what they can do instead of what they cannot do. Buttoning up shirts, putting on make-up, tying up shoes or even dancing and playing musical instruments. Simple, everyday tasks alongside a cheerful, feel-good tune developed specially for the campaign.
António Portela, CEO of Bial, explains the positive tone of the campaign: “Parkinson’s can really change people’s lives, but it’s very important that they do not lose their self-esteem. That is why we wanted to counter the negative portraits of people with Parkinson’s and show everyone what they really can do. Hopefully, we can inspire and empower the millions of people living with Parkinson’s to never give up on their dignity. Bial’s aim is to help the lives of people with Parkinson’s even if it’s to help with one small thing at a time.”
The campaign launches worldwide today – on World Parkinson’s Day – and is featured on Bial’s website, across Bial’s social media and on the European Parkinson’s Disease Association’s social media channels too.
Watch the video ‘Me at my best’ below
This article is sponsored by Bial. The information in this article is given for information purposes only and does not represent an endorsement by the EPDA of any particular treatments, products or companies. This article is not a substitute for advice from your doctor, pharmacist or other healthcare professional. Parkinson’s Life makes no representations or warranties of any kind, express or implied, about the completeness or accuracy of information provided.
Founded in 1924, Bial’s mission is to discover, develop and provide therapeutic solutions within the area of health. In recent decades, Bial has strategically focused on quality, innovation and internationalisation. Bial has channelled more than 20% of its annual turnover into research and development within neurosciences and the cardiovascular system.
In 2016 Bial launched Opicapone for Parkinson’s disease. Already available in Germany and in the United Kingdom, it will be introduced in the remaining European countries throughout 2017.
Currently representing around two thirds of its turnover, Bial will continue to strengthen its international presence based in its own innovative medicines, particularly in the most important European pharmaceutical markets, Spain, Germany, United Kingdom and Italy, where the company is already present with its own affiliates. For more information about Bial, please visit www.bial.com.
Fox Foundation offers $2m for ‘game-changing’ Parkinson’s breakthrough
Calling all researchers! $2m prize to develop imaging ‘tracer’ for key
2 weeks ago
Artificial intelligence to monitor Parkinson’s symptoms
Researchers at Massachusetts Institute of Technology, US have developed an artificial intelligence system that can monitor Parkinson’s symptoms from the other side of a solid wall. The x-ray technology – named RF-Pose – will use radio signals to sense individuals’ posture and movement. This will help medical professionals track the development of Parkinson’s and provide more effective care. Dina Katabi, professor of electrical engineering and computer science at Massachusetts Institute of Technology, said: “We’ve seen that monitoring patients’ walking speed and ability to do basic activities on their own gives healthcare providers a window into their lives that they didn’t have before. “A key advantage of our approach is that patients do not have to wear sensors or remember to charge their devices.”
The Michael J Fox Foundation awards $107,000 grant to new Parkinson’s study
The Michael J Fox Foundation has awarded a grant of US $107,000 to fund research into a newly discovered gene linked to Parkinson’s. The study – carried out by researchers from the University of Bordeaux, France and Purdue University, US – will investigate whether gene NFE2L1 can reduce nerve cell death in those living with the condition. Jean-Christophe Rochet, professor of medicinal chemistry and molecular pharmacology at Purdue University, said: “We recently found that a minor allele [part of a gene] of NFE2L1 can lower Parkinson’s risk. “These observations imply that neuron death in Parkinson’s disease may result in part from a loss of the neuroprotective action of NFE2L1.”
Pesticides could cause Parkinson’s, research finds
Researchers at a Canadian university have conducted a study that suggests pesticides may lead to Parkinson’s disease. As part of the study, the team used stem cells from people living with Parkinson’s to ascertain whether exposure to pesticides can cause mutations. The scientists leading the study found that neurons exposed to certain pesticides were low in energy and moved less freely. Dr Scott Ryan, professor of molecular and cellular biology at the University of Guelph, Ontario, Canada, said: “People exposed to these chemicals are at about a 250 per cent higher risk of developing Parkinson’s disease than the rest of the population.” Despite the results, the guidelines set for pesticides by many official bodies – including the United States Environmental Protection Agency – do not identify these chemicals as risks. The study concluded that safety guidelines for pesticides may need re-evaluation – and that those living in an agricultural environment…